€42.37
1.47% today
Xetra, Nov 26, 12:45 pm CET
ISIN
DE0005785802
Symbol
FME
Index

Fresenius Medical Care Stock price

€43.00
+3.98 10.20% 1M
+4.23 10.91% 6M
+5.04 13.28% YTD
+6.32 17.23% 1Y
-11.72 21.42% 3Y
-24.10 35.92% 5Y
-16.35 27.55% 10Y
Xetra, Closing price Mon, Nov 25 2024
+0.75 1.78%
ISIN
DE0005785802
Symbol
FME
Index
Sector

Key metrics

Market capitalization €12.62b
Enterprise Value €23.62b
P/E (TTM) P/E ratio 19.15
EV/FCF (TTM) EV/FCF 15.10
EV/Sales (TTM) EV/Sales 1.23
P/S ratio (TTM) P/S ratio 0.66
P/B ratio (TTM) P/B ratio 0.93
Dividend yield 2.77%
Last dividend (FY23) €1.19
Revenue growth (TTM) Revenue growth -1.15%
Revenue (TTM) Revenue €19.24b
EBIT (operating result TTM) EBIT €1.63b
Free Cash Flow (TTM) Free Cash Flow €1.56b
Cash position €1.37b
EPS (TTM) EPS €2.25
P/E forward 18.53
P/S forward 0.66
EV/Sales forward 1.23
Show more

Is Fresenius Medical Care a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Fresenius Medical Care Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Fresenius Medical Care forecast:

6x Buy
29%
9x Hold
43%
6x Sell
29%

Analyst Opinions

21 Analysts have issued a Fresenius Medical Care forecast:

Buy
29%
Hold
43%
Sell
29%

Financial data from Fresenius Medical Care

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
19,239 19,239
1% 1%
100%
- Direct Costs 14,403 14,403
1% 1%
75%
4,836 4,836
2% 2%
25%
- Selling and Administrative Expenses 1,457 1,457
0% 0%
8%
- Research and Development Expense 199 199
13% 13%
1%
3,180 3,180
2% 2%
17%
- Depreciation and Amortization 1,546 1,546
11% 11%
8%
EBIT (Operating Income) EBIT 1,634 1,634
9% 9%
8%
Net Profit 659 659
46% 46%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Fresenius Medical Care directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fresenius Medical Care Stock News

AD HOC NEWS
21 days ago
Die US-Bank JPMorgan hat das Kursziel für Fresenius Medical Care (FMC) DE0005785802 von 35,40 auf 37,30 Euro angehoben, aber die Einstufung auf "Underweight" belassen.
AD HOC NEWS
22 days ago
Beim Dialysespezialisten Fresenius Medical Care (FMC) DE0005785802 trägt der Konzernumbau weiter Früchte.
AD HOC NEWS
22 days ago
Beim Dialysespezialisten Fresenius Medical Care (FMC) DE0005785802 trägt der Konzernumbau weiter Früchte.
More Fresenius Medical Care News

Company Profile

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Head office Germany
CEO Helen Giza
Employees 119,845
Founded 1996
Website www.freseniusmedicalcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today